Oncotarget

Research Papers:

ICG-001 affects DRP1 activity and ER stress correlative with its anti-proliferative effect

Heidi Zinecker, Djamila Ouaret, Daniel Ebner, Moritz M. Gaidt, Steve Taylor, Anna Aulicino, Marta Jagielowicz, Veit Hornung and Alison Simmons _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:106764-106777. https://doi.org/10.18632/oncotarget.22264

Metrics: PDF 1755 views  |   HTML 3063 views  |   ?  


Abstract

Heidi Zinecker1, Djamila Ouaret2, Daniel Ebner3, Moritz M. Gaidt4, Steve Taylor5, Anna Aulicino1, Marta Jagielowicz1, Veit Hornung4 and Alison Simmons1

1MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, United Kingdom

2Department of Oncology, Cancer and Immunogenetics Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, United Kingdom

3Target Discovery Institute, University of Oxford, Oxford, OX3 7FZ, United Kingdom

4Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, 81377, Germany

5Computational Biology Research Group, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, United Kingdom

Correspondence to:

Alison Simmons, email: [email protected]

Keywords: DRP1; drug screening; ICG-001; ER stress; colorectal cancer

Received: February 08, 2017     Accepted: October 17, 2017     Published: November 01, 2017

ABSTRACT

Mitochondria form a highly dynamic network driven by opposing scission and fusion events. DRP1 is an essential modulator of mitochondrial fission and dynamics within mammalian cells. Its fission activity is regulated by posttranslational modifications such as activating phosphorylation at serine 616. DRP1 activity has recently been implicated as being dysregulated in numerous human disorders such as cancer and neurodegenerative diseases. Here we describe the development of a cell-based screening assay to detect DRP1 activation. We utilized this to undertake focused compound library screening and identified potent modulators that affected DRP1 activity including ICG-001, which is described as WNT/β-catenin signaling inhibitor. Our findings elucidate novel details about ICG-001’s mechanism of action (MOA) in mediating anti-proliferative activity. We show ICG-001 both inhibits mitochondrial fission and activates an early endoplasmic reticulum (ER) stress response to induce cell death in susceptible colorectal cancer cell lines.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22264